↓ Skip to main content

The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapy

Overview of attention for article published in Genome Medicine, July 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

twitter
19 tweeters

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapy
Published in
Genome Medicine, July 2019
DOI 10.1186/s13073-019-0661-7
Pubmed ID
Authors

Erich Sabio, Timothy A. Chan

Twitter Demographics

The data shown below were collected from the profiles of 19 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 20%
Student > Ph. D. Student 4 13%
Student > Master 4 13%
Other 2 7%
Professor > Associate Professor 2 7%
Other 5 17%
Unknown 7 23%
Readers by discipline Count As %
Medicine and Dentistry 10 33%
Biochemistry, Genetics and Molecular Biology 5 17%
Agricultural and Biological Sciences 3 10%
Immunology and Microbiology 1 3%
Unspecified 1 3%
Other 0 0%
Unknown 10 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2020.
All research outputs
#2,237,480
of 17,175,498 outputs
Outputs from Genome Medicine
#519
of 1,144 outputs
Outputs of similar age
#51,501
of 267,112 outputs
Outputs of similar age from Genome Medicine
#1
of 1 outputs
Altmetric has tracked 17,175,498 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,144 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.4. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 267,112 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them